Calls for IVF laws to be changed to take advantage of gene editing technique
By Steve Connor,
The Independent
| 09. 02. 2015
Untitled Document
Britain may need to change its IVF laws to allow the genetic modification of human embryos so that scientists can use a gene-editing technique that could eliminate certain inherited diseases, leading biomedical organisations warn.
At present it is illegal to alter the genes of reproductive “germ cells” such as eggs, sperm and embryos, but the clinical benefits of modifying the human germ-line could one day outweigh the ethical objections, says a statement by two government research councils and a coalition of medical research charities.
While the US has imposed a moratorium on the use of genome editing of human embryos, the joint statement implies that the day might soon come in the UK when it is ethically justified to implant the first genetically modified embryo in a womb. The research organisations, which include the Medical Research Council and the Wellcome Trust, Britain’s biggest medical charity, said there was no reason why the gene-editing technique known as Crispr-Cas9 should not be used immediately on early IVF embryos for research purposes provided they are not implanted into the womb –...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...